China Railwy Gp: (OTC: CRWOY)
$11.62
-0.31 (-2.60%)
Volume 3,000
Apr 17 09:30 AM ET
Zacks Rank: 3-Hold 
| #3 |
Overview Quote
Stock Activity
| Day Low - High | 11.62 - 11.63 |
| 52wk Low - High | 8.27 - 15.93 |
| Previous Close | 11.93 |
| Avg. Volume | 0 |
| Industry | BLDG-HEAVY CNST |
| Market Cap | 1.96 B |
| Div - Yield | 0.16 - 1.34 |
| Beta | 0.98 |
| PE (Forward) | 8.01 |
| Current Year Est. | 1.45 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
3 |
Zacks Recommendation
|
No Zacks Recommendation |
Zacks Industry Rank
|
116 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| PE (Forward) | 8.01 |
| PEG Ratio | NA |
| Current Year Est. | 1.45 |
| Current Quarter Estimate | NA |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | NA |
| EPS Last Year | NA |
| Expected Earnings Growth | NA |
Company Description
China Railway Group Limited is engaged in construction business in the People's Republic of China and internationally. China Railway Group Limited has participated in the construction of domestic major railway lines and constructed, rebuilt and extended its total length. China Railway has also been involved in the construction of bridges, tunnels, expressways and metropolitan railways. In addition, China Railway is also engaged in construction and construction-related services for overseas projects including railway, expressway, highway, bridge, tunnel, building construction, dredging, airport and municipal work projects in many countries.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (03/2013) |
Next Qtr (06/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | NA | NA | 1.45 | 1.37 |
| Number of Estimates | 0 | 0 | 1 | 1 |
| Low Estimate | NA | NA | 1.45 | 1.37 |
| High Estimate | NA | NA | 1.45 | NA |
| Year Ago EPS | NA | NA | NA | 1.45 |
| EPS Growth | NA | NA | NA | -5.52% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| CHINA RAILWY GP | CRWOY | 11.62 | |
|
| PRIMORIS SERVCS | PRIM | 21.27 | |
|
| CHICAGO BRIDGE | CBI | 61.76 | |
|
| ORION MARINE GP | ORN | 11.75 | |
|
| CHINA COMM CONS | CCCGY | 19.40 | |
|
| CHINA RAILWY CP | CWYCY | 10.26 | |
|
| DYCOM INDS | DY | 20.09 | |
|
| EMCOR GROUP INC | EME | 40.75 | |
|
| EMPRESAS ICA | ICA | 10.67 | |
|
| HOPEWELL HWY IN | HHILY | 4.96 | |
|
Sector:Construction>> Industry:BLDG-HEAVY CNST
COMPARE TICKER vs. Its Peers
Financials
| EPS TTM | NA |
| Sales | 68,543 |
| Net Income | NA |
| Price/Earnings | NA |
| Price/Book | NA |
| Price/Cash Flow | 0.97 |
| Price/Sales | NA |
News
Auxilium Pharmaceuticals to Present at UBS Global Health Care Conference - Close-Up Media
May 21, 2013
Post Earnings Update: Auxilium Pharmaceuticals Has Climbed 7.2% Higher in Past 2 Weeks (AUXL) - Financial News Network Online - Earnings Lookback
May 18, 2013
Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference - Pr Newswire
May 15, 2013
Auxillium Pharmaceuticals (AUXL) Showing Bearish Technicals But Could Break Through $15.69 Resistance - Freshbrewedmedia
May 15, 2013
Buyers Accumulate Shares of Auxilium Pharmaceuticals, Up 1.4% - Financial News Network Online - Market Movers
May 14, 2013
Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference - Pr Newswire
May 10, 2013
Buyers Accumulate Shares of Auxilium Pharmaceuticals, Up 1.4% - Financial News Network Online - Market Movers
May 10, 2013
Auxillium Pharmaceuticals (AUXL) Showing Bearish Technicals But Could Fall Through $14.61 Support - Freshbrewedmedia
May 9, 2013
Broker Recommendations
| Current ABR | 3.00 |
| ABR (Last Week) | 3.00 |
| # of recs in ABR | 1 |
| Average Target Price | NA |
| Industry Rank by ABR | 116 out of 265 |
| Rank in Industry | 5 out of 18 |
